France · Investor

M/VENTURES

Last cheque observed Oct 2026; 20 cheques on record.

Email

VC firmDeploying nowLast fund, Jan 2018

Series ASeries BGrowthVenture Capital & Private Equity

Deploying now
100%of best year4cheques in 12 months, 20 on record
Since the last cheque17days00hrs00min00sec
Median round$29MRounds led6 of 20Sole investor1 roundsMostly inUnited States, 63%
Pitch M/VENTURES

Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. Tell us which if you know.

M/VENTURES highlights

  1. 01

    4 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 89% of its rounds

  3. 03

    Sole investor in 1 rounds, median $16M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Venture Capital & Private Equity
Based in
Toulouse, France
Cold pitches
Not stated

The record

Every round we can evidence, newest first20 appearances

  1. 2026

    3 rounds

  2. Oct
    NouscomSeries D · CH · Revelation Partners$135MLed
  3. Oct
    Mueon Corp.Series A · US · Pulse 2.0$65MWith 8 others
  4. Aug
    QuintessentSeries A · US · Ventureburn$40MWith 12 others
  5. 2025

    3 rounds

  6. Nov
    Ferroelectric Memory Company (FMC)Growth · DE · DTCF DeepTech & Climate Fonds$116MWith 6 others
  7. Sept
    NRG TherapeuticsSeries B · GB · Firms' own news pages$68MWith 6 others
  8. Jul
    ActitheraSeries A · GB · 4BIO Capital$76MLed
  9. 2023

    1 round

  10. Sept
    CellFESeries A · Elm Street Ventures$22MLed
  11. 2022

    2 rounds

  12. Dec
    Sonde HealthSeries B · US · Evidity Health Capital$19MWith 4 others
  13. Nov
    Concerto BiosciencesSeries A · US · Firms' own news pages$23MWith 3 others
  14. 2019

    8 rounds

  15. Dec
    NeurableSeries A · US · FinSMEs$6.0MLed
  16. Nov
    ImmunitasSeries A · US · FinSMEs$39MWith 4 others
  17. Nov
    FanAISeries A · US · Gamesindustry$8.0MWith 7 others
  18. Oct
    PlexiumSeries A · US · Plexium$28MWith 4 others
  19. May
    AltoidaSeries A · CH · FinSMEs$6.3MLed
  20. May
    DNA ScriptSeries B · FR · FinSMEs$39MWith 6 others
  21. Apr
    SondeUS · Bioportfolio$16MSole investor
  22. Mar
    BiolinqSeries A · US · FinSMEs$4.8MWith 4 others
  23. 2018

    2 rounds

  24. Nov
    RibometrixSeries A · US · FinSMEs$30MLed
  25. Aug
    ArtiosSeries B · GB · FinSMEs$83MWith 7 others
  26. 2017

    1 round

  27. Nov
    WiliotUS · FinSMEs$5.0MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration4 named

AMAdrian Malik FentyManaging MemberiForm ADV
CDCharles David KingManaging MemberiForm ADV
MRMichael Richard PalankManaging MemberiForm ADV
MPMike PalankMember of the General PartneriFiling they signed

We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$27Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Macro Ventures LLC
SEC number
CRD 296621

What they claim to have backed

From their own portfolio page (on their website)

0 of 6 we have independently watched raise

CanvaslivingCreatrehubElevatereiThepinnaclecorpVarsitylaWyreco

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as M/VENTURES. A count of rooms they were both in, not a relationship either has claimed.

AbbVieCorporate VC2rounds togetherAlexandria Real Estate EquitiesVC firm2rounds togetherAndera PartnersPrivate equity2rounds togetherBpifranceGovernment2rounds togetherNovartis Venture FundCorporate VC2rounds togetherSafar PartnersVC firm2rounds together

Recently backed

The latest companies M/VENTURES put money into.

Nouscom$135M · Oct 2026Quintessent$40M · Aug 2026NRG Therapeutics$68M · Sept 2025Actithera$76M · Jul 2025CellFE$22M · Sept 2023Concerto Biosciences$23M · Nov 2022

Quick answers about M/VENTURES

What does M/VENTURES invest in?

M/VENTURES invests most often at Series A and Series B (89% of the rounds on record), in sectors such as Venture Capital & Private Equity.

How active is M/VENTURES?

20 investments on record, 4 of them in the last 12 months, and it led 6. The most recent was in Oct 2026.

What has M/VENTURES invested in recently?

Its most recent investments on record: Nouscom (Series D, Oct 2026), Mueon Corp. (Series A, Oct 2026) and Quintessent (Series A, Aug 2026).

How big are M/VENTURES's cheques?

The median round it joins is $29M.

Does M/VENTURES lead rounds?

Yes: it led 6 of its 20 investments on record (30%).

Where does M/VENTURES invest?

Most of the companies it backs are in the United States (63%), the United Kingdom (16%) and Switzerland (11%).

Is M/VENTURES investing now?

Yes: it is actively investing, with 4 investments in the last 12 months.

Who does M/VENTURES invest alongside?

Most often AbbVie (2 rounds together), Alexandria Real Estate Equities (2 rounds together) and Andera Partners (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it